These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 10148951)

  • 1. Two new nonradioisotopic immunoassays for TSH.
    Tam SC; Pang WC
    J Int Fed Clin Chem; 1990 Apr; 2(2):76-9. PubMed ID: 10148951
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical value comparison between chemiluminescent immunoassay and immunoradiometric assay in detecting TSH in serum].
    Yu JY; Lin Y
    Hunan Yi Ke Da Xue Xue Bao; 2003 Jun; 28(3):275-7. PubMed ID: 14653089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elecsys thyrotropin (TSH) assay evaluated.
    Sapin R; Gasser F; d'Herbomez M; Wemeau JL; Ebert C; Schlienger JL
    Clin Chem; 1997 Mar; 43(3):545-7. PubMed ID: 9068604
    [No Abstract]   [Full Text] [Related]  

  • 4. [Development of monoclonal antibody-based immunoenzyme kit for detection of human thyrotropin hormone].
    Sigal ER; Koriazova LK; Kovalevskaia GI; Pozdniakova TA; Kandyba EI; Kuznetsov VA; Vasilov RG
    Klin Lab Diagn; 1997 Apr; (4):21-4. PubMed ID: 9221072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of canine serum thyrotropin (TSH) concentration: comparison of three analytical procedures.
    Marca MC; Loste A; Orden I; González JM; Marsellá JA
    J Vet Diagn Invest; 2001 Mar; 13(2):106-10. PubMed ID: 11289204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between TRH-stimulated TSH and basal TSH measurement by a commercial immunoradiometric assay in the management of thyroid disease.
    De Rosa G; Testa A; Giacomini D; Carrozza C; Maussier ML; Valenza V; D'Errico GF
    Q J Nucl Med; 1996 Jun; 40(2):182-7. PubMed ID: 8909104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyrotropin and thyroid antibodies as predictors of hypothyroidism: a 13-year, longitudinal study of a community-based cohort using current immunoassay techniques.
    Walsh JP; Bremner AP; Feddema P; Leedman PJ; Brown SJ; O'Leary P
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1095-104. PubMed ID: 20097710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum TSH within the reference range as a predictor of future hypothyroidism and hyperthyroidism: 11-year follow-up of the HUNT Study in Norway.
    Åsvold BO; Vatten LJ; Midthjell K; Bjøro T
    J Clin Endocrinol Metab; 2012 Jan; 97(1):93-9. PubMed ID: 22049180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunochemiluminometric assay for measurement of thyrotropin in various thyroid disorders.
    Chailurkit L; Rajatanavin R
    J Med Assoc Thai; 1993 Sep; 76(9):501-5. PubMed ID: 7964256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-like growth factor 1 reference intervals for a chemiluminescent enzyme immunometric assay (Immulite 2000®) in an adult Mediterranean population.
    Candás-Estébanez B; Solé-Enrech G; Pérez-Contreras ME; Padró-Miquel A; Alía P; Navarro-Moreno MÁ
    Clin Chem Lab Med; 2011 Dec; 50(5):965-6. PubMed ID: 22628321
    [No Abstract]   [Full Text] [Related]  

  • 11. New immunoelectrochemiluminometric assay to measure serum thyrotropin.
    Sotorrío P; Quirós A; Izquierdo JM
    Clin Chem; 1997 Dec; 43(12):2428-30. PubMed ID: 9439469
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of a new chemiluminescence technique for human thyrotropin (BeriLux hTSH): diagnostic value of five immunometric assay methods.
    Hashimoto T; Matsubara F; Nishibu M; Kawai K
    Eur J Clin Chem Clin Biochem; 1991 Nov; 29(11):753-7. PubMed ID: 1782283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitive immunoradiometric assay for thyrotropin to distinguish primary hyperthyroidism and secondary hypothyroidism from normals.
    Lee YJ; Tsai JH; Shin SJ; Torng JK; Lai YH; Pan JS; Her SS; Wu CC
    Taiwan Yi Xue Hui Za Zhi; 1986 Dec; 85(12):1169-76. PubMed ID: 3102683
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevalence of abnormal thyrotropin concentrations measured by a sensitive assay in patients with type 2 diabetes mellitus.
    Celani MF; Bonati ME; Stucci N
    Diabetes Res; 1994; 27(1):15-25. PubMed ID: 7648793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T4 and ultrasensitive TSH immunoassays using luminescent enhanced xanthine oxidase assay.
    Baret A; Fert V
    J Biolumin Chemilumin; 1989 Jul; 4(1):149-53. PubMed ID: 2678912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Assessment of basal and stimulated TSH in overt and subclinical hyperthyroidism].
    Reinhardt M; Schümichen C; Schächtele S; Zimmerlin M; Moser E
    Nuklearmedizin; 1995 Apr; 34(2):61-5. PubMed ID: 7761275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical significance of thyrotropin measurement by immunoradiometric assay and thyrotropin-releasing hormone test].
    Luo GC
    Zhonghua Yi Xue Za Zhi; 1993 Jun; 73(6):355-7, 382. PubMed ID: 8258107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applications of a new chemiluminometric thyrotropin assay to subnormal measurement.
    Spencer CA; LoPresti JS; Patel A; Guttler RB; Eigen A; Shen D; Gray D; Nicoloff JT
    J Clin Endocrinol Metab; 1990 Feb; 70(2):453-60. PubMed ID: 2105333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subclinical thyroid disease: clinical applications.
    Col NF; Surks MI; Daniels GH
    JAMA; 2004 Jan; 291(2):239-43. PubMed ID: 14722151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new modular chemiluminescence immunoassay analyser evaluated.
    Ognibene A; Drake CJ; Jeng KY; Pascucci TE; Hsu S; Luceri F; Messeri G
    Clin Chem Lab Med; 2000 Mar; 38(3):251-60. PubMed ID: 10905763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.